Oral insulin reloaded: A structured approach

Journal of Diabetes Science and Technology

Volumn 8, Issue 3, 2014, Pages 458-465

  Zijlstra, Eric ^a   Heinemann, Lutz ^a   Plum Mörschel, Leona ^a  

^a Profil   (Germany)

Author keywords

Bioavailability; Diabetes; Enteral absorption; Glycemic control; Oral delivery; Oral insulin

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUSTRY; GLYCEMIC CONTROL; HUMAN; INTESTINE ABSORPTION; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; TREATMENT OUTCOME;

EID: 84900815258     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814529988     Document Type: Conference Paper

References (20)

1. Harrison GA. Insulin in alcoholic solution by the mouth. Br Med J. 1923;2:1204-1205.
2. Al-Tabakha MM, Arida AI. Recent challenges in insulin delivery systems: a review. Indian J Pharm Sci. 2008;70:278-286.
3. Aronson R. The role of comfort and discomfort in insulin therapy. Diabetes Technol Ther. 2012;14:741-747.
4. Heinemann L, Jacques Y. Oral and buccal insulin: a critical reappraisal. J Diabetes Sci Technol. 2009;3:568-584.
5. Eldor R, Arbit E, Schurr D, Kidron M, Hersko A. Dose response to oral insulin capsules in fasting, healthy subjects. Diabetes. 2013;62(suppl 1):1054-P.
6. Eldor R, Kidron M, Miteva Y, Arbit E. Decreased CRP levels in response to a six-week, once-daily oral insulin regimen. 81st EAS Congress, Lyon, France. 2013;47.
7. Khedkar A, Iyer H, Anand A, et al. A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects. Diabetes Obes Metab. 2010;12: 659-664.
8. Iyer H, Khedkar A, Verma M. Oral insulin - a review of current status. Diabetes Obes Metab. 2010;12:179-185.
9. Suryanarayan S, Khedkar A, Vedala A, et al. Pharmacokinetics and pharmacodynamics of a single oral dose of the insulin analog IN-105, in tablet form, in normal healthy volunteers, in the presence of food. Diabetologia. 2007;50(suppl 1): S95-S96.
10. Phillips J, Russel-Jones DL, Wright J, Brackenridge A, New R, Bansal G. Early evaluation of a novel oral insulin delivery system in healthy volunteers. Diabetes. 2004;53 (suppl 2):A113.
11. Luzio SD, Dunseath G, Lockett A, Broke-Smith TP, New RR, Owens DR. The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes. Diabetes Obes Metab. 2010;12:82-87.
12. Whitelaw DC, Kelly CA, Ironmonger W, Cunliffe CM, New R, Phillips JN. Absorption of orally ingested insulin in human type 1 diabetic subjects: proof of concept study. Diabetes. 2005;54(suppl 1):5-LB.
13. Kapitza C, Zijlstra E, Heinemann L, Castelli MC, Riley G, Heise T. Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Diabetes Care. 2010;33:1288-1290.
14. Goldberg M, Dinh S, Castelli C, Majuru S, Arbit E. Improved glycemic control with oral recombinant human insulin in patients with type 2 diabetes (T2DM) inadequately controlled on metformin. Diabetes. 2007;56(suppl 2):A121.
15. Elsayed A, Al-Remawi M, Farouk A, Badwan A. Insulinchitosan polyelectrolyte nanocomplexes: Preparation, characterization and stabilization of insulin. Sudan JMS. 2010;5:99-110.
16. Badwan A, Remawi M, Qinna N, et al. Enhancement of oral bioavailability of insulin in humans. Neuro Endocrinol Lett. 2009;30:74-78.
17. Eldor R, Kidron M, Arbit E. Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects. Diabetes Obes Metab. 2010;12:219-223.
18. Eldor R, Arbit E, Miteva Y, Freier R, Kidron M. Oral insulin: type 1 diabetes (T1DM) patient response upon preprandial administration. Diabetes. 2010;59(suppl 1):521-P.
19. Eldor R, Arbit E, Corcos A, Kidron M. Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study. PLOS ONE. 2013;8:e59524.
20. Li J, Wang Y, Han L, Sun X, Yu H, Yu Y. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers. Clin Ther. 2012;34:2333-2338.